Jeff Yass’s Climb Bio CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.09M Buy
182,400
+155,600
+581% +$2.17M ﹤0.01% 6158
2026
Q2
$349K Buy
+26,800
New +$277K ﹤0.01% 10717

Other funds holding CLYM

Jeff Yass's CLYM Position: Q3 2026 in Review

Jeff Yass increased its Climb Bio (CLYM) stake by 50% in Q3 2026, buying an estimated $213K and bringing the position to 45,550 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #9648.

Jeff Yass first reported a position in CLYM in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.65M in Q1 2026. 127 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • Jeff Yass held 45,550 shares of Climb Bio worth $522K as of Q3 2026.
  • Jeff Yass bought 15,271 Climb Bio shares in Q3 2026, an estimated $213K.
  • Climb Bio made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9648 holding.
  • Jeff Yass first reported a position in Climb Bio in Q4 2024 and has held it in 8 quarters since.
  • Jeff Yass's Climb Bio position peaked at $2.65M in Q1 2026.
  • 127 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.